Supriya S. Venugopal

A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa

Supriya S. Venugopal, Wenfei Yan, John W. Frew et al. · Journal of the American Academy of Dermatology · 2013 · 113 citations

Medicine, Cutaneous Biology, Pathology +7

Development of a Quality-of-Life Instrument for Autoimmune Bullous Disease

Deshan F. Sebaratnam, Anna Marie Hanna, Shien‐Ning Chee et al. · JAMA Dermatology · 2013 · 80 citations · Full text

Recalcitrant Cutaneous Warts Treated With Recombinant Quadrivalent Human Papillomavirus Vaccine (Types 6, 11, 16, and 18) in a Developmentally Delayed, 31-Year-Old White Man

Supriya S. Venugopal · Archives of Dermatology · 2010 · 72 citations

Multiple Warts, Recalcitrant Cutaneous Warts, Immunology +22

The development and validation of the Treatment of Autoimmune Bullous Disease Quality of Life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease

Angelina Tjokrowidjaja, Benjamin S. Daniel, John W. Frew et al. · British Journal of Dermatology · 2013 · 72 citations

Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)

Clement C.H. Loh, Jaehwan Kim, John Su et al. · Journal of the American Academy of Dermatology · 2013 · 69 citations

Cutaneous Biology, Pathology, Clinical Dermatology +7